FDA Approves Iberdomide Combo for Relapsed or Refractory Multiple Myeloma
Related coverage: FDA Approves Iberdomide Combo for Relapsed or Refractory Multiple Myeloma Medscape
Aug 14, 2026
Publisher
Medscape News
The latest headlines and summaries aggregated from Medscape on AIMode News.
1 recent stories from Medscape
Advertisement
Advertisement
Health
FDA Approves Iberdomide Combo for Relapsed or Refractory Multiple Myeloma
Related coverage: FDA Approves Iberdomide Combo for Relapsed or Refractory Multiple Myeloma Medscape
Medscape ·